Applications

Curates checkpoint, costimulatory and effector-toolkit reagents—with custom expression services—for discovery-stage immunotherapy programs.

Bundles tumor-associated antigens, activation tool antibodies and analytical proteins for adoptive cell-engineering workflows.

Focuses on hallmark and next-gen tumor antigens powering CAR design, expansion assays and cytotoxic readouts.

Bridges tumor-cell, angiogenic and myeloid axes to interrogate the TME alongside combination IO strategies.

Delivers reference proteins, calibrators and immunogenicity-readout reagents for ELISA, cytometry and cytokine panels.

Supports TAM-, MDSC- and phagocytic-checkpoint biology for cold-tumor and metabolic IO translation.

Supplies antigens and scaffold proteins for T-cell engagers and asymmetric bispecific modalities with CRO-scale expression.

Highlights internalizing, surface-stable antigen domains to study linker-payload coupling and trafficking kinetics.

Spans RTKs, angiocrine mediators and epithelial lineage antigens underpinning solid-tumor-directed biologics.

Centers TNFR superfamilies bridging innate sensing and adaptive boosters—ideal for agonist IO discovery.

Charts pro-/anti-inflammatory and fibrosis cytokines with homolog controls for autoimmune and CRS-related studies.

Feeds multiplex Luminex-/bead-panel programs with calibrated reference matrices and orthogonal controls.